What did @pavlasazamova actually say?
The transcript provided appears to be garbled or misattributed, and does not match the caption content. Based on the available caption, @pavlasazamova is making a pointed claim: doctors treating autoimmune conditions like psoriasis, thyroid disease, Crohn's, ulcerative colitis, multiple sclerosis, and rheumatoid arthritis "don't know the cause" and therefore "only suppress symptoms" rather than treating the disease itself. The implied question is whether lifelong treatment is actually necessary.
This framing, common in alternative health content, positions conventional medicine as fundamentally reactive and incomplete, and hints that another approach, presumably what she's selling or promoting via her "comment CHCI for more info" call-to-action, can do better. We'll assess whether any of that holds up.
Does the science back this up?
Partially, and that's the frustrating part. The claim that medicine "doesn't know the cause" of autoimmune disease is outdated and oversimplified, but not entirely baseless. The critique that most treatments suppress rather than resolve the underlying immune dysfunction is genuinely accurate in many cases.
Autoimmune conditions do share a poorly understood pathogenesis. Genetic susceptibility, gut microbiome disruption, environmental triggers, and immune dysregulation all contribute. Research from Fasano et al. (2012, Clinical Reviews in Allergy and Immunology) identified intestinal permeability as a plausible contributing mechanism in several autoimmune conditions. This is real science. However, calling this "doctors don't know the cause" is a rhetorical sleight of hand. Researchers understand a great deal about mechanism, even if root-cause prevention remains elusive. Saying medicine is ignorant misrepresents decades of immunology research.
- Rheumatoid arthritis: HLA-DRB1 gene variants are well-established risk factors
- Multiple sclerosis: Epstein-Barr virus is now strongly implicated as a trigger (Bjornevik et al., 2022, Science)
- Psoriasis: IL-17 and IL-23 pathways are well-mapped, which is why biologics targeting them work
What did they get wrong (or right)?
Credit where it's due: the observation that most conventional autoimmune treatments are suppressive rather than curative is largely accurate. Methotrexate, corticosteroids, biologics, and immunosuppressants manage disease activity. They don't reliably produce permanent remission in most patients. That's a fair critique and one that immunologists themselves acknowledge openly.
Where the framing goes wrong is the implication that this means medicine has failed, and that an alternative can succeed. The leap from "current treatments suppress symptoms" to "there is a better path" requires evidence, not just skepticism. Many patients achieve sustained remission on biologics. Some inflammatory bowel disease patients reach mucosal healing, which goes beyond symptom suppression. The claim that treatment "must be for life" is also an oversimplification. Some patients with Crohn's or psoriasis do achieve long drug-free remission periods, particularly after early aggressive treatment.
The hashtag category context here is peptide therapy, which includes compounds like BPC-157 and TB-500. Animal studies on BPC-157 show anti-inflammatory effects (Seiwerth et al., 2014, Current Pharmaceutical Design), but no robust human clinical trials support using peptides to treat or reverse any autoimmune condition. That gap matters enormously.
What should you actually know?
If you have an autoimmune condition and this video made you wonder whether you can ditch your medication, here's the honest picture. Lifestyle interventions, including diet modification, stress reduction, sleep, and gut health, do have real, peer-reviewed support for reducing disease activity in some autoimmune conditions. A 2017 study in Cell reported that fasting-mimicking diets showed potential in multiple sclerosis mouse models, though human data remains preliminary.
What doesn't have that support is stopping prescribed immunosuppressants without medical supervision. Uncontrolled autoimmune flares can cause permanent organ or joint damage in diseases like lupus and RA. The pitch implied in this video, that a different approach can replace conventional care, needs to be held to the same evidentiary standard as any drug. Curiosity about root-cause medicine is reasonable. Abandoning treatment based on an Instagram caption is not.
Peptides like BPC-157 are not approved by any regulatory body for treating autoimmune disease. Anyone suggesting otherwise is running ahead of the evidence.